CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Clinical trial NCT04660929 · UNKNOWN

Trial details

NCT number: NCT04660929
Sponsor: Carisma Therapeutics Inc
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-positive Adenocarcinoma Bile Duct Cancer Biliary Tract Cancer Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Ductal Carcinoma, Hepatocellular Cancer Lung Cancer, Non-Small-Cell Carcinoma, Ovarian Epithelial

Start date: 2021-02-02
Primary completion: 2024-12-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.